Teva Pharmaceutical Industries
TEVA
#713
Rank
NZ$56.52 B
Marketcap
NZ$49.26
Share price
0.18%
Change (1 day)
62.62%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - Cash on Hand

Cash on Hand as of September 2025 : NZ$3.81 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company has NZ$3.81 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Teva Pharmaceutical Industries - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$5.85 B14.71%
2023-12-31NZ$5.10 B15.63%
2022-12-31NZ$4.41 B39.19%
2021-12-31NZ$3.16 B5.05%
2020-12-31NZ$3.01 B2.89%
2019-12-31NZ$2.93 B10.39%
2018-12-31NZ$2.65 B95.92%
2017-12-31NZ$1.35 B-4.93%
2016-12-31NZ$1.42 B-85.95%
2015-12-31NZ$10.14 B257.22%
2014-12-31NZ$2.84 B124.92%
2013-12-31NZ$1.26 B-63.91%
2012-12-31NZ$3.49 B149.21%
2011-12-31NZ$1.40 B-15.62%
2010-12-31NZ$1.66 B-46.23%
2009-12-31NZ$3.09 B-5.82%
2008-12-31NZ$3.28 B-12.45%
2007-12-31NZ$3.75 B29.36%
2006-12-31NZ$2.90 B-10.35%
2005-12-31NZ$3.23 B121.83%
2004-12-31NZ$1.45 B-31.25%
2003-12-31NZ$2.12 B6.21%
2002-12-31NZ$1.99 B5%
2001-12-31NZ$1.90 B98.63%
2000-12-31NZ$0.95 B430.33%
1999-12-31NZ$0.18 B93.49%
1998-12-31NZ$93.35 M-7.55%
1997-12-31NZ$0.10 B3.1%
1996-12-31NZ$97.94 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
NZ$16.88 B 342.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$18.09 B 374.44%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$7.69 B 101.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$25.93 B 580.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$31.52 B 726.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.36 B-64.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
NZ$14.16 B 271.40%๐Ÿ‡ฌ๐Ÿ‡ง UK